Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Medical Bulletin|March 5, 2010
New understanding and approaches to treatment in rheumatoid arthritisJean H Tayar, Maria E Suarez-Almazor
The Cochrane Database of Systematic Reviews|November 16, 2012
Febuxostat for treating chronic goutJean H Tayar, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor
Seminars in Arthritis and Rheumatism|June 19, 2018
Myositis as an adverse event of immune checkpoint blockade for cancer therapyMohsin Shah, Jean H Tayar, Noha Abdel-Wahab, et al.
Drugs & Aging|May 18, 2025
Managing Rheumatoid Arthritis in Older Adults with CancerMaria A Lopez-Olivo, Aliza R Karpes Matusevich, Jean H Tayar, et al.
The Cochrane Database of Systematic Reviews|May 20, 2026
Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activityYuanteng J Li, Maria Angeles Lopez-Olivo, Yimin Geng, et al.
JAMA|September 6, 2012
Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysisMaria A Lopez-Olivo, Jean H Tayar, Juan A Martinez-Lopez, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2021
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitorsNoha Abdel-Wahab, Adi Diab, Robert K Yu, et al.
Blood Advances|April 28, 2020
Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumorsNoha Abdel-Wahab, Jean H Tayar, Faisal Fa'ak, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic CholangiocarcinomaTimothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
Cancers|August 12, 2023
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint InhibitorsMaria A Lopez-Olivo, Johncy J Kachira, Maryam Buni, et al.
Pageof 2